Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    Admissibility Of Stem Cell Therapy - Case Law Update Austria

    The question arose in the context of (administrative) criminal proceedings against a doctor.
    AustriaFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Your Web Doctor Will See You Now - Software As A Medical Device

    Patients nowadays have access to an enormous range of medical knowledge through social media, websites and health apps.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Healthcare Update - Mastering New Trends: Teleradiology*

    Technology and innovation are key drivers of advancement in a variety of industries, and certainly in healthcare. The level of patient care can be improved considerably with the right mix...
    AustriaFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Happy New Regulation: The New Health Technology Assessment Regulation Kicks Off In Early 2025

    Health technologies, such as pharmaceuticals, medical devices and in-vitro diagnostics, play a key role in the success and progress of our healthcare system.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Leucopenia Medicine And Reimbursement Code

    The financing of the Austrian healthcare system by the social security institutions differs between the inpatient and the outpatient sector:
    AustriaFood, Drugs, Healthcare, Life Sciences
    Preslmayr Rechtsanwälte OG
    Preslmayr Rechtsanwälte OG
  • Article

    The End Of A Dry Spell – NIS 2 Published

    After several delays, the revision of the NIS Directive was published in the Official Journal of the European Union on 27 December 2022 in the form of Directive (EU) 2022/2555 ("NIS 2").
    European UnionTechnology
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Revitalising Healthcare: Austria's New Healthcare Reform

    Austria's healthcare system got a long-anticipated makeover. After years of small-scale adjustments, a collective amendment – the "Vereinbarungsumsetzungsgesetz 2024"...
    AustriaFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Gold Rush With Disinfectants

    Unbelievable but true – due to the outbreak of COVID-19, hand and surface disinfectants are currently hardly available anywhere in the shops.
    AustriaFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Medical Devices In CEE & SEE: Navigating The Challenges To Modern Healthcare

    The list of entities subject to monitoring and certain reporting obligations in Austria extends beyond the provisions of the MDR and the IVDR. It includes persons and entities that use medical devices...
    AustriaFood, Drugs, Healthcare, Life Sciences
    Wolf Theiss
    Wolf Theiss
  • Article

    Genome Editing - CRISPR/Cas9

    Genome editing designates new methods that allow targeted interventions to be carried out in the genetic material, the genome of a cell (1).
    AustriaFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    Blood, Tissue, Cells And More – New EU Regulation On Substances Of Human Origin

    In Austria, almost 1,000 units of stored blood are needed every day; in Germany, it is around 15,000 units.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Schoenherr (Schönherr Rechtsanwälte)
    Schoenherr (Schönherr Rechtsanwälte)
  • Article

    DRInsider - April 2018

    Welcome to the 10th edition of the DRInsider, the quarterly Newsletter of the Wolf Theiss Dispute Resolution Group. We provide an overview of recent developments in CEE/SEE and some very interesting case law.
    GlobalLitigation, Mediation & Arbitration
    Wolf Theiss
    Wolf Theiss

Showing 1–12 of 12 results

Legal Intelligence Newsletters